Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6656-0.0044 (-0.66%)
At close: 08:02AM CEST
Full screen
Previous Close0.6700
Open0.6656
Bid0.6678 x 1500000
Ask0.7096 x 1500000
Day's Range0.6656 - 0.6656
52 Week Range0.6226 - 0.8750
Volume2,500
Avg. Volume1,452
Market Cap8.094B
Beta (5Y Monthly)0.69
PE Ratio (TTM)11.09
EPS (TTM)0.0600
Earnings DateAug 21, 2024 - Aug 26, 2024
Forward Dividend & Yield0.03 (5.00%)
Ex-Dividend DateMay 31, 2024
1y Target EstN/A
  • Reuters

    FOCUS-China's drugmakers can't sell mRNA shots but haven't quit yet

    China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.